MEDI-547
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEDI-547, covering 2011-11-17 to 2011-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of MEDI-547 to Evaluate the Safety, Tolerability, and Biologic Activity of IV Administration in Subjects With Relapsed or Refractory Solid Tumors [Phase 1]